| Dr Earlie Hill Francis Iii, MD | |
|
457 W Birdie Ln, Magnolia, DE 19962-3263 | |
| (607) 644-2399 | |
| Not Available |
| Full Name | Dr Earlie Hill Francis Iii |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 457 W Birdie Ln, Magnolia, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831148212 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD050860L (Pennsylvania) | Secondary |
| 207P00000X | Emergency Medicine | C1-0012830 (Delaware) | Primary |
| Entity Name | Pennsylvania Urgent Care Centers, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902128721 PECOS PAC ID: 8123200631 Enrollment ID: O20110304000289 |
News Archive
Efforts to remove barriers to accessing emergency contraception (EC) scored victories in 2013, when the U.S. Food and Drug Administration removed age restrictions on over-the-counter sales of the levonogestrel drug Plan B. But those who need EC can still encounter cost and availability barriers.
Atherosclerosis - a disease that includes the buildup of fatty, cholesterol-laden lumps of cells inside the artery wall - is the underlying cause of heart attacks and strokes.
Ascletis, Inc., a U.S.-China specialty life sciences venture focused on cancer and infectious disease therapeutics, today announced the company's formation and completion of a Series A private equity financing. Ascletis has raised US$100 million in committed financing including a first tranche of US$50 million. The investors, led by Hangzhou Binjiang Investment Holding Co., Ltd., included private entrepreneurs from China and other countries including the United States.
A recent CDC report on HIV/AIDS in the U.S. - which found that about 56,000 new HIV infections occur in the U.S. each year - "should serve as a wake-up call from the AIDS amnesia surrounding the domestic epidemic in recent years," Susan Blumenthal, senior policy and medical adviser at the Foundation for AIDS Research, and Melissa Shive, a former research assistant at amfAR and medical student at the University of California-San Francisco, write in a Washington Times opinion piece.
› Verified 8 days ago
| Entity Name | Novus Pain Management - Pennsylvania Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821581737 PECOS PAC ID: 7416206123 Enrollment ID: O20180814000708 |
News Archive
Efforts to remove barriers to accessing emergency contraception (EC) scored victories in 2013, when the U.S. Food and Drug Administration removed age restrictions on over-the-counter sales of the levonogestrel drug Plan B. But those who need EC can still encounter cost and availability barriers.
Atherosclerosis - a disease that includes the buildup of fatty, cholesterol-laden lumps of cells inside the artery wall - is the underlying cause of heart attacks and strokes.
Ascletis, Inc., a U.S.-China specialty life sciences venture focused on cancer and infectious disease therapeutics, today announced the company's formation and completion of a Series A private equity financing. Ascletis has raised US$100 million in committed financing including a first tranche of US$50 million. The investors, led by Hangzhou Binjiang Investment Holding Co., Ltd., included private entrepreneurs from China and other countries including the United States.
A recent CDC report on HIV/AIDS in the U.S. - which found that about 56,000 new HIV infections occur in the U.S. each year - "should serve as a wake-up call from the AIDS amnesia surrounding the domestic epidemic in recent years," Susan Blumenthal, senior policy and medical adviser at the Foundation for AIDS Research, and Melissa Shive, a former research assistant at amfAR and medical student at the University of California-San Francisco, write in a Washington Times opinion piece.
› Verified 8 days ago
| Entity Name | Sayre Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831209113 PECOS PAC ID: 7416955000 Enrollment ID: O20220317002858 |
News Archive
Efforts to remove barriers to accessing emergency contraception (EC) scored victories in 2013, when the U.S. Food and Drug Administration removed age restrictions on over-the-counter sales of the levonogestrel drug Plan B. But those who need EC can still encounter cost and availability barriers.
Atherosclerosis - a disease that includes the buildup of fatty, cholesterol-laden lumps of cells inside the artery wall - is the underlying cause of heart attacks and strokes.
Ascletis, Inc., a U.S.-China specialty life sciences venture focused on cancer and infectious disease therapeutics, today announced the company's formation and completion of a Series A private equity financing. Ascletis has raised US$100 million in committed financing including a first tranche of US$50 million. The investors, led by Hangzhou Binjiang Investment Holding Co., Ltd., included private entrepreneurs from China and other countries including the United States.
A recent CDC report on HIV/AIDS in the U.S. - which found that about 56,000 new HIV infections occur in the U.S. each year - "should serve as a wake-up call from the AIDS amnesia surrounding the domestic epidemic in recent years," Susan Blumenthal, senior policy and medical adviser at the Foundation for AIDS Research, and Melissa Shive, a former research assistant at amfAR and medical student at the University of California-San Francisco, write in a Washington Times opinion piece.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Earlie Hill Francis Iii, MD 457 W Birdie Ln, Magnolia, DE 19962-3263 Ph: (607) 644-2399 | Dr Earlie Hill Francis Iii, MD 457 W Birdie Ln, Magnolia, DE 19962-3263 Ph: (607) 644-2399 |
News Archive
Efforts to remove barriers to accessing emergency contraception (EC) scored victories in 2013, when the U.S. Food and Drug Administration removed age restrictions on over-the-counter sales of the levonogestrel drug Plan B. But those who need EC can still encounter cost and availability barriers.
Atherosclerosis - a disease that includes the buildup of fatty, cholesterol-laden lumps of cells inside the artery wall - is the underlying cause of heart attacks and strokes.
Ascletis, Inc., a U.S.-China specialty life sciences venture focused on cancer and infectious disease therapeutics, today announced the company's formation and completion of a Series A private equity financing. Ascletis has raised US$100 million in committed financing including a first tranche of US$50 million. The investors, led by Hangzhou Binjiang Investment Holding Co., Ltd., included private entrepreneurs from China and other countries including the United States.
A recent CDC report on HIV/AIDS in the U.S. - which found that about 56,000 new HIV infections occur in the U.S. each year - "should serve as a wake-up call from the AIDS amnesia surrounding the domestic epidemic in recent years," Susan Blumenthal, senior policy and medical adviser at the Foundation for AIDS Research, and Melissa Shive, a former research assistant at amfAR and medical student at the University of California-San Francisco, write in a Washington Times opinion piece.
› Verified 8 days ago